Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels
- 1 December 2003
- journal article
- review article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 307 (3) , 831-838
- https://doi.org/10.1124/jpet.103.054569
Abstract
Phenotypic variation within a species arises from differences in genetic makeup between individuals. This inherent diversity empowers the species as a whole to explore and expand into new environmental niches and also to survive new stressors within an ever-changing environment. Paradoxically, one class of stressors currently challenging the human population is therapeutic drugs: medications designed to combat disease are often associated with a host of nonspecific side effects. Following earlier studies of the involvement of some cardiac ion currents in unwanted drug interactions, recent reports have identified not only the ion channel subunits involved but also a range of mutations and single nucleotide polymorphisms in ion channel genes that predispose to both drug-induced and familial cardiac arrhythmia. The tendency for individuals harboring specific, often common, gene variants to succumb to life-threatening cardiac arrhythmia, and the contribution of other factors such as drug interaction to disease etiology in these cases, are discussed here together with potential pharmacogenetic strategies for arrhythmia circumvention and therapy.Keywords
This publication has 40 references indexed in Scilit:
- The Incorporation of an Ion Channel Gene Mutation Associated with the Long QT Syndrome (Q9E-hMiRP1) in a Plasmid Vector for Site-Specific Arrhythmia Gene Therapy:In VitroandIn VivoFeasibility StudiesHuman Gene Therapy, 2003
- Pharmacological Rescue of Human K + Channel Long-QT2 MutationsCirculation, 2002
- Disease‐associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanismThe FASEB Journal, 2002
- Normalization of Ventricular Repolarization with Flecainide in Long QT Syndrome Patients with SCN5A:ΔKPQ MutationAnnals of Noninvasive Electrocardiology, 2001
- Mutations in the hminK gene cause long QT syndrome and suppress lKs functionNature Genetics, 1997
- A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndromeNature Genetics, 1997
- Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channelNature, 1996
- Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasNature Genetics, 1996
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channelCell, 1995
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell, 1995